Scientists find way to ‘press self-destruct button’ in gastric cancer associated with Epstein-Barr Virus

Mod­er­na has inked a deal worth up to $1.8 bil­lion with TCR spe­cial­ist Im­mat­ics that broad­ens the com­pa­ny’s po­si­tion in mR­NA-based can­cer re­search. The Cam­bridge,

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

Legal and clinical experts around the country agreed that a recent Supreme Court ruling did not not materially change the status of abortions in Idaho